R&D channel feed

Star­board launch­es first sal­vo in Pfiz­er fight, al­leg­ing ex-CEO, CFO were pres­sured to flip

7 months ago

Grit­stone files for bank­rupt­cy, says it could forge a trans­ac­tion as ear­ly as this month to keep R&D go­ing

7 months ago
Financing

‘Just the be­gin­ning’: No­bel Prizes show the AI era has ar­rived in biotech

7 months ago
AI

Clear­side shares jump as re­for­mu­lat­ed TKI drug pass­es mid-stage test in wet AMD

7 months ago

David Bak­er, Demis Has­s­abis and John Jumper win chem­istry No­bel for com­pu­ta­tion­al pro­tein pre­dic­tion and de­sign

7 months ago
People

AI biotech in­sitro part­ners with Lil­ly on meta­bol­ic dis­ease drugs

7 months ago
Deals
AI

GSK's RSV vac­cine Arexvy shows long-term pro­tec­tion in Phase 3 tri­al

7 months ago
Pharma

Pfiz­er culls RSV treat­ment from Re­Vi­ral ac­qui­si­tion

7 months ago
Pharma

Ex­clu­sive: A small San Diego biotech wants to change how Parkin­son’s dis­ease is di­ag­nosed

7 months ago
Financing

Black Di­a­mond cuts work­force, pri­or­i­tizes lung can­cer drug

7 months ago
People

Bio­gen to seek ap­proval for high-dose Spin­raza af­ter un­veil­ing new da­ta

7 months ago
Pharma

Sage faces third study fail in six months as Alzheimer's can­di­date miss­es Phase 2 goal

7 months ago

J&J’s ‘pret­zel’ drug-de­vice ther­a­py fails in cer­tain blad­der can­cer pa­tients

7 months ago
Pharma

Schol­ar Rock claims suc­cess in Phase 3 spinal mus­cu­lar at­ro­phy study, stock soars

7 months ago

As­traZeneca makes an­oth­er car­dio deal, bet­ting $100M on Chi­na com­pa­ny’s lipid drug

7 months ago
Deals

Ju­do Bio launch­es with $100M for kid­ney-tar­get­ed siR­NA ther­a­pies

7 months ago

FDA puts Kezar lu­pus tri­al on hold af­ter ear­li­er re­port of pa­tient deaths

7 months ago

J&J dis­con­tin­ues mid-stage dengue study, cit­ing de­pri­or­i­ti­za­tion of com­mu­ni­ca­ble dis­ease work

7 months ago
Pharma

Ex­clu­sive: Re­lay Ther­a­peu­tics cuts an­oth­er 10% of com­pa­ny, cit­ing con­tin­ued stream­lin­ing ef­forts

7 months ago
People

Op­di­vo gets FDA ap­proval for use around lung can­cer surgery, fol­low­ing Keytru­da and Imfinzi

7 months ago
FDA+

Enara Bio’s $32.5M Se­ries B to sup­port lead dark anti­gen pro­gram for GI can­cers

7 months ago
Financing

BioN­Tech opens the hood on its AI am­bi­tions, and they're not just for mR­NA

7 months ago
AI

Wave’s new cap­i­tal ex­tends cash run­way in­to 2027, CEO says

7 months ago

Lil­ly in­vests $4.5B in new In­di­ana site to bring clin­i­cal man­u­fac­tur­ing in-house

7 months ago
Pharma
Manufacturing
First page Previous page 23242526272829 Next page Last page
A service from the Financial Times